Investigator
Yan Chen
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · funded by NEI
- Companies
- 2
- Grants
- 2
- Non-dilutive funding
- $362k
- First award
- Aug 1, 2016
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
On this record.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- Guangdong Association of Clinical Trials100momentum
OncologyPhase III
- Guang An Mojia Biotechnology Co., Ltd.Momentum in another area
ImmunologyFiled/Approved
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- R01
Aberrant RPE mTORC1 signaling in dysregulation of choroid homeostasis
$3kAug 1, 2016NEIUNIVERSITY OF OKLAHOMA HLTH SCIENCES CTRNIH RePORTER · 11092736 (opens the source filing in a new tab)
- R01
Aberrant RPE mTORC1 signaling in dysregulation of choroid homeostasis
$359kAug 1, 2016NEIUNIVERSITY OF TEXAS HLTH SCI CTR HOUSTONNIH RePORTER · 11479819 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources